Claritev officer proposes sale of 5,812 shares
The reported prior sale was 8,850 common shares on August 14, 2026, for gross proceeds of $354,592.95.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Claritev Corp (CTEV) officer Tiffani Misencik reported a proposed sale of 5,812 common shares, with an estimated aggregate market value of $139,139.28 and an approximate sale date of October 15, 2026. The shares are listed as acquired from Claritev through restricted stock units on October 14, 2026; Morgan Stanley Smith Barney LLC is named as broker, and NYSE as the exchange. Misencik also reported selling 8,850 common shares on August 14, 2026, for gross proceeds of $354,592.95.
Key Figures
Key Terms
Restricted Stock Units financial
Rule 144 regulatory
Aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.